Bilge Targıtay Ozturk, Fatih Ozel, Tutku Yaras, Burcu Ekinci, Yavuz Oktay, Elif Onur Aysevener, Tunc Alkın, Neşe Direk
{"title":"心血管疾病风险与重度抑郁症的关系","authors":"Bilge Targıtay Ozturk, Fatih Ozel, Tutku Yaras, Burcu Ekinci, Yavuz Oktay, Elif Onur Aysevener, Tunc Alkın, Neşe Direk","doi":"10.29399/npa.28191","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Cardiovascular risk in depression has been investigated in small clinical samples and population-based studies revealing inconclusive results. However, cardiovascular risk in drug-naive depressed patients has not been tested extensively.</p><p><strong>Methods: </strong>Body mass index-based Framingham Cardiovascular Risk Scores and soluble intercellular adhesion molecule-1 (sICAM-1) levels were used to assess the risk of cardiovascular disease in drug-naive depressed patients and healthy volunteers.</p><p><strong>Conclusion: </strong>There were no significant differences in Framingham Cardiovascular Risk Scores and individually assessed risk variables between patients and healthy controls (HC). Both groups were comparable in terms of sICAM-1.</p><p><strong>Results: </strong>The widely recognized association between cardiovascular risk and major depression might be more prominent in older depressed patients and patients with recurring episodes.</p>","PeriodicalId":74318,"journal":{"name":"","volume":"60 2","pages":"124-128"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242288/pdf/archneuro-60-124.pdf","citationCount":"0","resultStr":"{\"title\":\"The Relationship Between Cardiovascular Disease Risk and Major Depression.\",\"authors\":\"Bilge Targıtay Ozturk, Fatih Ozel, Tutku Yaras, Burcu Ekinci, Yavuz Oktay, Elif Onur Aysevener, Tunc Alkın, Neşe Direk\",\"doi\":\"10.29399/npa.28191\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Cardiovascular risk in depression has been investigated in small clinical samples and population-based studies revealing inconclusive results. However, cardiovascular risk in drug-naive depressed patients has not been tested extensively.</p><p><strong>Methods: </strong>Body mass index-based Framingham Cardiovascular Risk Scores and soluble intercellular adhesion molecule-1 (sICAM-1) levels were used to assess the risk of cardiovascular disease in drug-naive depressed patients and healthy volunteers.</p><p><strong>Conclusion: </strong>There were no significant differences in Framingham Cardiovascular Risk Scores and individually assessed risk variables between patients and healthy controls (HC). Both groups were comparable in terms of sICAM-1.</p><p><strong>Results: </strong>The widely recognized association between cardiovascular risk and major depression might be more prominent in older depressed patients and patients with recurring episodes.</p>\",\"PeriodicalId\":74318,\"journal\":{\"name\":\"\",\"volume\":\"60 2\",\"pages\":\"124-128\"},\"PeriodicalIF\":0.0,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242288/pdf/archneuro-60-124.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.29399/npa.28191\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.29399/npa.28191","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Relationship Between Cardiovascular Disease Risk and Major Depression.
Introduction: Cardiovascular risk in depression has been investigated in small clinical samples and population-based studies revealing inconclusive results. However, cardiovascular risk in drug-naive depressed patients has not been tested extensively.
Methods: Body mass index-based Framingham Cardiovascular Risk Scores and soluble intercellular adhesion molecule-1 (sICAM-1) levels were used to assess the risk of cardiovascular disease in drug-naive depressed patients and healthy volunteers.
Conclusion: There were no significant differences in Framingham Cardiovascular Risk Scores and individually assessed risk variables between patients and healthy controls (HC). Both groups were comparable in terms of sICAM-1.
Results: The widely recognized association between cardiovascular risk and major depression might be more prominent in older depressed patients and patients with recurring episodes.